These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19016100)

  • 1. Preparation and evaluation of 2-(allylthio)pyrazine-loaded lipid emulsion with enhanced stability and liver targeting.
    Jang JH; Kim CK; Choi HG; Sung JH
    Drug Dev Ind Pharm; 2009 Mar; 35(3):363-8. PubMed ID: 19016100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of ligustrazine-loaded lipid emulsion: formulation optimization, characterization and biodistribution.
    Wei L; Marasini N; Li G; Yong CS; Kim JO; Quan Q
    Int J Pharm; 2012 Nov; 437(1-2):203-12. PubMed ID: 22944305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new alternative for intravenous lipid emulsion 20% w/w from superolein oil and its effect on lipid and liver profiles in an animal model.
    Amran MHH; Zulfakar MH; Danik MF; Abdullah MSP; Shamsuddin AF
    Daru; 2019 Jun; 27(1):191-201. PubMed ID: 31020546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation and in vitro and in vivo evaluation of etoposide submicro-emulsion for intravenous injection].
    Tian LL; Tang X; He HB; Wang J
    Yao Xue Xue Bao; 2007 Aug; 42(8):892-7. PubMed ID: 17944242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization, and
    Geng D; Li Y; Wang C; Ren B; Wang H; Wu C; Zhang Y; Zhao L; Zhao L
    Drug Deliv; 2021 Dec; 28(1):873-883. PubMed ID: 33960250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS; Lee MG
    Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid emulsion as a drug delivery system for breviscapine: formulation development and optimization.
    Wei L; Li G; Yan YD; Pradhan R; Kim JO; Quan Q
    Arch Pharm Res; 2012 Jun; 35(6):1037-43. PubMed ID: 22870813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving cabazitaxel chemical stability in parenteral lipid emulsions using cholesterol.
    Shao Y; Zhang C; Yao Q; Wang Y; Tian B; Tang X; Wang Y
    Eur J Pharm Sci; 2014 Feb; 52():1-11. PubMed ID: 24153395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous administration to rabbits.
    Han KS; Woo SJ; Koo CH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):29-34. PubMed ID: 9644716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of emulsifying agents on disposition of lipid-soluble drugs included in fat emulsion.
    Suzuki Y; Masumitsu Y; Okudaira K; Hayashi M
    Drug Metab Pharmacokinet; 2004 Feb; 19(1):62-7. PubMed ID: 15499171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic changes of intravenous 2-(allylthio) pyrazine, a chemoprotective agent, in rats with acute renal failure induced by uranyl nitrate.
    Lee EJ; Kim EJ; Kim YG; Chung HC; Kim SH; Kim DH; Lee I; Kim SG; Lee MG
    Res Commun Mol Pathol Pharmacol; 2002; 111(5-6):225-36. PubMed ID: 15244038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of incorporation methods on partitioning behavior of lipophilic drugs into various phases of a parenteral lipid emulsion.
    Sila-on W; Vardhanabhuti N; Ongpipattanakul B; Kulvanich P
    AAPS PharmSciTech; 2008; 9(2):684-92. PubMed ID: 18496755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of commercial parenteral lipid emulsions repacking to polypropylene syringes.
    Watrobska-Swietlikowska D
    PLoS One; 2019; 14(4):e0214451. PubMed ID: 30970011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting.
    Seki J; Sonoke S; Saheki A; Fukui H; Sasaki H; Mayumi T
    Int J Pharm; 2004 Apr; 273(1-2):75-83. PubMed ID: 15010132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naproxen incorporated lipid emulsions. I. Formulation and stability studies.
    Nasirideen S; Kaş HS; Oner F; Alpar R; Hincal AA
    J Clin Pharm Ther; 1998 Feb; 23(1):57-65. PubMed ID: 9756113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Providing a Combination Lipid Emulsion Compared With a Standard Soybean Oil Lipid Emulsion in Children Receiving Parenteral Nutrition: A Systematic Review and Meta-Analysis.
    Finn KL; Chung M; Rothpletz-Puglia P; Byham-Gray L
    JPEN J Parenter Enteral Nutr; 2015 Aug; 39(6):656-67. PubMed ID: 25057053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions.
    Sakaeda T; Hirano K
    J Drug Target; 1998; 6(4):273-84. PubMed ID: 9894695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel.
    Gao K; Sun J; Liu K; Liu X; He Z
    Drug Dev Ind Pharm; 2008 Nov; 34(11):1227-37. PubMed ID: 18720137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of curcumin microemulsions with food-grade soybean oil/lecithin and their cytotoxicity on the HepG2 cell line.
    Lin CC; Lin HY; Chi MH; Shen CM; Chen HW; Yang WJ; Lee MH
    Food Chem; 2014 Jul; 154():282-90. PubMed ID: 24518344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical properties of structured phosphatidylcholine in drug carrier lipid emulsions for drug delivery systems.
    Kawaguchi E; Shimokawa K; Ishii F
    Colloids Surf B Biointerfaces; 2008 Mar; 62(1):130-5. PubMed ID: 17988839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.